Section 182-530-4000 - Drug use review (DUR) boardIn accordance with 42 C.F.R. 456.716, the medicaid agency establishes a drug use review (DUR) board.
(1) The DUR board: (a) Includes health professionals who are actively practicing and licensed in the state of Washington and who have recognized knowledge and expertise in one or more of the following: (i) The clinically appropriate prescribing of outpatient drugs;(ii) The clinically appropriate dispensing and monitoring of outpatient drugs;(iii) Drug use review, evaluation, and intervention; and(iv) Medical quality assurance.(b) Is made up of at least one-third but not more than fifty-one percent physicians, and at least one-third pharmacists.(2) The agency may appoint members of the pharmacy and therapeutics committee established by the agency under chapter 182-50 WAC or other qualified individuals to serve as members of the DUR board.(3) The DUR board meets periodically to:(a) Advise the agency on drug use review activities;(b) Review provider and patient profiles;(c) Review scientific literature to establish evidence-based guidelines for the appropriate use of drugs, including the appropriate indications and dosing;(d) Recommend adoption of standards and treatment guidelines for drug therapy;(e) Recommend interventions targeted toward correcting drug therapy problems; and(f) Produce an annual report.(4) The agency has the authority to accept or reject the recommendations of the DUR board in accordance with 42 C.F.R. 456.716(c).Wash. Admin. Code § 182-530-4000
Amended by WSR 16-01-046, Filed 12/9/2015, effective 1/9/201611-14-075, recodified as § 182-530-4000, filed 6/30/11, effective 7/1/11. Statutory Authority: RCW 74.04.050, 74.08.090, 74.09.530, and 74.09.700. 07-20-049, § 388-530-4000, filed 9/26/07, effective 11/1/07.